Health services & technology · Patient access and copay support

Medmonk

It began as a pharmacist’s spreadsheet for finding money for patients who could not pay for their drugs. Fourteen years on, it is a small, pharma-funded hub and copay operator for rare disease brands, and its headquarters has moved from California to Illinois.

Forty minutes per patient

Somaira Punjwani was the pharmacist in charge at a Walgreens in Miami. Her patients were sick with HIV, hepatitis C, rheumatoid arthritis and cancer, and many could not afford the medicine that kept them alive.

So she built a workaround. “I created a spreadsheet of sources that could provide financial assistance. On average, it would take me about 40 minutes of phoning and faxing to assist a single patient,” she told Y Combinator in a founder interview. The work paid off in ways she could see. “Patients were so happy that they would often break down in tears because they could finally access their medication.”

It did not scale. A pharmacist with a full counter cannot spend 40 minutes on the phone for every patient. That arithmetic is the company.

The problem

A specialty drug can carry a copay of thousands of dollars. Manufacturers often fund copay and patient assistance programs to keep patients on therapy, but each program has its own rules, forms and caps. The XEMBIFY program that Medmonk administers is typical: commercially insured patients only, up to $10,000 over a calendar year, claims due within 60 days of dispensing, and no eligibility for anyone on Medicare, Medicaid, Tricare or another government plan.

Someone has to run those rules at scale, at the pharmacy counter or through a billing portal, and someone has to pay for it. Medmonk’s answer changed over time. The Y Combinator listing still describes a tool for pharmacists. The current business is different, and the change is the most important fact about the company.

Founders

Punjwani earned her Pharm.D. at Palm Beach Atlantic University in 2007. She built the manual process at Walgreens and, according to the company, it was later adopted nationwide by the chain. That Walgreens claim is company-stated and no independent source confirms it.

Abbas Mehdi, her husband, is an electrical and computer engineer from the University of British Columbia who worked at Research In Motion on BlackBerry Enterprise Server and later as a product manager at iolo technologies. A third co-founder, Yong, is described in the interview as Mehdi’s friend from the same UBC program. No surname appears in the sources found.

Mehdi served as CEO for eleven years, the company says. He has since moved to Chief Product Officer. The chief executive is now Ashar Hasan, a pharmacist who founded Premier Specialty Infusion, a Hoffman Estates, IL home infusion company acquired by PromptCare, and who earlier ran Rx Solutions before it was bought by Walgreens/Option Care.

From tool to hub

Medmonk went through Y Combinator’s Winter 2012 batch and took part in Rock Health, per its own about page and Y Combinator’s blog. A database entry dated October 2016 records a second seed round. One CB Insights page carries a news item that says Medmonk won INR 1 crore from two Indian investors on a television pitch show that month. That item does not say it is the same company, so treat the link as likely but unproven.

The 2026 company is a different animal. Its site sells to pharma market access leaders: point of sale copay enrollment, benefit investigation, prior authorization, patient assistance and adherence analytics for rare disease and specialty brands. Rx Almanac, a vendor directory, describes it as “a hub and copay technology company that pharma manufacturers pay to run patient access for rare disease and immunology brands.”

What is proven, and what is still claimed

Read plainly: Medmonk is a real, long-running operator with named manufacturer programs and a credible pharmacy-side leadership bench, but almost all performance claims come from the company itself. Its capital story is thin and mostly database-sourced.

What to watch

• Named customers. Only Grifols’ XEMBIFY program is documented with the brand owner on the page. Any public contract or press release from a manufacturer would settle the testimonials.
• Ownership and funding. PitchBook records a June 2025 secondary transaction with no amount. A Form D or a company statement would show who holds the equity.
• Leadership handoff. The CEO change from Mehdi to Hasan, and Hasan’s conference role at the 2026 Hub and Specialty Pharmacy Models East meeting, show a leadership team drawn from specialty pharmacy and infusion.
• Regulatory exposure. Copay programs are shaped by payer policy on accumulators and maximizers, and the sources found do not discuss how Medmonk handles that.

In their words

Related companies

• Alfie: Also in Healthcare Services. A New York telehealth clinic that used an AI model called ObesityRx to match patients with weight loss medications and behavior changes
• Science Exchange: Also in Healthcare Services. A marketplace for ordering experiments that became procurement software for big pharma, and that sourced the laboratories for the largest public test of whether
• HealthSherpa: Also in Healthcare Services. A Sacramento company that rebuilt the front end of HealthCare.gov for agents and carriers
• Synapticure: Also in Healthcare Services. A virtual specialty clinic for ALS, Parkinson’s and dementia, built by an ALS patient and his caregiver

Sources

1. InterviewFemale Founder Stories: Somaira Punjwani, Founder of Medmonk (YC W12)Y Combinator blog · Feb 8, 2015
2. IndependentMedmonk vendor profileRx Almanac · Sep 23, 2026
3. IndependentPremier Specialty Infusion Acquired by PromptCareThe Braff Group · 2017
4. IndependentMedmonk profile and reviewsVettedRx · 2026
5. IndependentMedmonk funding rounds and investorsTracxn · accessed Sep 2026
6. IndependentMedmonk company profilePitchBook · Jul 31, 2026
7. IndependentMedmonk products, financials and headquartersCB Insights · accessed Sep 2026
8. IndependentMedmonk company pageMTEC · Feb 13, 2025
9. IndependentAffordable and Accessible Treatments for JMCure JM Foundation · Sep 2023
10. IndependentAshar Hasan speaker profile, Hub Conference 2026Informa Connect · Mar 2026
11. IndependentMedmonk YC company profileAltss · 2025
12. Public recordCapture history for gamunex-c.medmonk.com and factorforhealth.medmonk.comInternet Archive
13. PartnerXEMBIFY copay assistance portalMedmonk, Grifols program · archived Mar 24, 2025
14. CompanyAbout UsMedmonk · Jun 9, 2026
15. CompanyHome page and testimonialsMedmonk · Aug 3, 2026
16. CompanyMedmonk company descriptionY Combinator company directory · Sep 29, 2026